Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2001 3
2002 1
2004 1
2005 2
2006 1
2008 2
2009 2
2010 5
2011 5
2012 3
2013 2
2014 3
2015 3
2016 6
2017 5
2018 3
2019 3
2020 6
2021 6
2022 4
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Kostidi
Page 1
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
Galanis E, Dooley KE, Keith Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ, Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC, Giannini C, Raghunathan A, Iankov ID, Parney IF. Galanis E, et al. Nat Commun. 2024 Jan 12;15(1):493. doi: 10.1038/s41467-023-43076-7. Nat Commun. 2024. PMID: 38216554 Free PMC article. Clinical Trial.
Personalizing Oncolytic Immunovirotherapy Approaches.
Stergiopoulos GM, Iankov I, Galanis E. Stergiopoulos GM, et al. Mol Diagn Ther. 2024 Mar;28(2):153-168. doi: 10.1007/s40291-023-00689-4. Epub 2023 Dec 27. Mol Diagn Ther. 2024. PMID: 38150172
A few introductory notes on the special issue on the Evaluation Framework for Promoting Gender Equality in Research and Innovation (EFFORTI).
Marra M. Marra M. Eval Program Plann. 2020 Apr;79:101767. doi: 10.1016/j.evalprogplan.2019.101767. Epub 2019 Dec 4. Eval Program Plann. 2020. PMID: 31869622
Before presenting this special issue, I owe many thanks to Jonny Morell who involved me in its design as early as June 2018. I also want to thank Susanne Buhrer, Clemens Striebing, Evanthia Kalpazidou Schmidt, Rachel Palmen, Sybille Reidl, Florian Holzinger and Jorg Muller …
Before presenting this special issue, I owe many thanks to Jonny Morell who involved me in its design as early as June 2018. I also want to …
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.
Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG 2nd, Galanis E. Brastianos PK, et al. J Clin Oncol. 2023 Jan 20;41(3):618-628. doi: 10.1200/JCO.21.02371. Epub 2022 Oct 26. J Clin Oncol. 2023. PMID: 36288512 Free PMC article. Clinical Trial.
66 results